Interesting to read the recent investor presentation from IRythym (a GMV competitor for the Patch only), including
- 58% CAGR increase in revenue for the past 5 years
- 75% gross margin.
Their revenue is predominantly from US operations.
It remains to be seen if GMed can produce this in US, or UK or China.
GMV Price at posting:
16.0¢ Sentiment: Buy Disclosure: Held